Summary Multidrug resistance (MDR) in tumour cells is often caused bv the overexpression of the plasma membrane drug transporter P-glycuprutein (P-gp) or the recently discosered multidrug resistance-associated protein (MRP). In this studs we insvestigated the specificity and sensitivity of the fluorescent probes rhodamine 123 (R123). daunorubicin (DNR) and calcein acetoxymethvl ester (calcein-AM) in order to detect the function of the drug transporters P-gp and MRP. using flow cytometrv. The effects of modulators on the accumulation and retention of these probes were compared in seseral pairs of sensitise and P-gp-as w-ell as MRPoserexpressing cell lines. R123. in combination with the modulator PSC833. provided the most sensitise test for detecting P-gp-mediated resistance. Moreoser. in a 60 min drug accumulation assay RI 23 can be regarded as a P-p-specific probe. since R123 is not ver-efficiently effluxed bv MRP. In contrast to R123. a 60 mm DNR or calcein-AM accumulation test could be used to detect MRP-mediated resistance The MRP-specific modulator genistein could be used in combination with DNR. but not w-ith calcein-AM. Vincristine (VCR) can be used to increase the cellular uptake of calcein-AM in MDR cells. but is not specific for MRP Thus.
acquired. is a major cause of failure in the curative treatment of haematological malignancies. Among the most active anticancer agents used in the treatment of haematological malignancies are some natural toxin-derived drugs. such as the anthracycline daunorubicin (DNR). the epipodophy llotoxin etoposide and the yinca alkaloid vincristine (VCR) . Development of cross-resistance to these structurally and functionally unrelated drugs is called multidrug resistance (MDR) . One type of MDR is caused by the overexpression of a plasma membrane protein. P-glycoprotein (P-gp) . the product of the .DR1 gene (Endicott and Ling. 1989) . P-gp functions as an ATP-dependent drug efflux pump. which results in lower intracellular drug concentrations and, hence. in drug resistance (Bradley et al.. 1988: Broxterman and Pinedo, 1991) . In some haematological malignancies, such as acute myeloid leukaemias. non-Hodgkin's lymphomas and multiple myelomas. P-gp expression appears to be a poor prognostic factor which might predict refractonrness (Grogan et al.. 1993) . In vitro. MDR can be circumvented by many relatively non-cvtotoxic agents. such as calcium channel blockers and cyclosporins (Nooter et al.. 1990 : Miller et al.. 1991 . Therefore. the possibility of reversing MDR in the clinic has attracted considerable interest.
In addition to P-gp-mediated MDR. a number of in vitro drug-selected tumour cell lines which do not contain P-gp but nevertheless show the MDR phenotype have been described (Kuiper et al.. 1990 : Versantsoort et al.. 1992 . Several, but not all. of these non-P-gp MDR cell lines show overexpression of the gene encoding the multidrug resistance-associated protein (MRRP) . which was recently cloned bv Cole et al. (1992) from the non-P-gp MDR small-cell lung cancer cell line H69AR. MRP is a 180-195 kDa membrane glvcoprotein which, like P-gp. belongs to the ATP-binding cassette (ABC) superfamilv of membrane transport proteins (Higgins. 1992 Gene transfection studies have demonstrated that MRP acts as a plasma membrane drug efflux pump and that MfRP overexpression increases resistance to a w-ide spectrum of natural product drugs (Grant et al.. 1994 : Broxterman and Versantvoort. 1995 .
Detection and characterisation of resistant cells in clinical tumour samples could become an important diagnostic parameter in clinical practice. Detection of MDR is mostly performed by using gene-specific probes to detect mRNA (overexpression or monoclonal antibodies to detect the corresponding proteins (Fojo et al.. 1987 : Van der Valk et al.. 1990 ). However. since MDR is caused by increased drug transport out of the cell. the best wsay of measuring would be to determine the free intracellular drug concentration. By measuring the drug accumulation in the cells. interpretation problems resulting from differences in post-translational modifications of the pump proteins (Center. 1985) and differences in passive drug uptake through the plasma membrane (Spoelstra et al.. 1992) (Zijlstra et al., 1987; Versantvoort et al., 1995a Flens et al.. 1994) . Antibody binding was detected with rabbit anti-rat fluorescein isothiocyanate (1:100) (Dakopatts). The mean of the fluorescence of the MRK16-or MRP-labelled cells was divided by the mean of the fluorescence of the non-relevant antibody-labelled cells.
Flow-through sYstem
The flow-through sy stem has been described in detail previously ). Basically. a monolayer of approximately 10 cells attached to a glass chamber (surface 50 cm2. height 0.1 mm) was perfused with 2 ILM DNR in medium A. The perfusion medium was passed over the cells at a constant flow of 200 jlI min-at 37°C until a steady-state level was reached. Then a series of pulse injectionsk of modulators was introduced into the flowing perfusion medium. causing inhibition of the DNR efflux. which was measured at the outlet of the flow-through system as a decrease in the medium fluorescence of DNR. The fluorescence of DNR was measured by a fluorescence detector (type 821-FP. Jasco. Haschioji City. Japan) at excitation emission wavelengths of 480 nm 560 nm.
Results

P-gp functional assays
Standard fluorescent probes for measuring the function of P-gp by flow cytometry are R123 and DNR (Lampidis et al., 1985; Van Acker et al., 1993) . A more recently investigated probe for P-gp is calcein-AM (Hollo et al., 1994; Homolya et al.. 1993) . In this study we compared these probes in order to assess their sensitivity and specificity for P-gp and MRP detection in accumulation and retention assays. First, we determined the accumulation ratio (the ratio of the fluorescence of drugs accumulated in the resistant and sensitive cell line) for these probes and the effect of the P-gp inhibitor PSC833 on their accumulation in the KB cell lines. Solubilisation of the cells with SDS after accumulation of the dyes confirmed that the effect of modulator on calcein and R123 fluorescence was indeed caused by an increased dye uptake. This excludes the possibility that the higher calcein or R123 fluorescence induced by the modulators is due to an altered intracellular drug distribution, resulting in a higher fluorescence of cells. In particular, the analysis of a slightly resistant cell line, such as KB8 (see last column of Table I for P-gp expression), is cn'tical in these assays, since this low level of resistance appears to be relevant for leukaemias (Schuurhuis et al.. 1995) . Table I shows that a reduced DNR accumulation can be detected in KB8 and KB8-5 cells compared with the sensitive parental KB3-1 cells. R123 and calcein accumulation were reduced in KB8-5, but not in the KB8 cell line. However, in the KB8 cell line a distinct effect of the P-gp modulator PSC833 on the R123 accumulation could be detected, and this effect of PSC833 was greater than the effect on DNR accumulation. In contrast, P-gp function in KB8 could not be detected by PSC833 modulation of calcein-AM uptake. Thus. the combination of PSC833 with Figure 1 shows the time course of the R123 accumulation and retention with and without PSC833 in the KB8 cell line. The relative effect of PSC833 on the accumulation and retention was somewhat larger when the accumulation and efflux time respectively were longer (not shown). However, in order to compare the sensitivity of an accumulation and retention assay, time points of 60 min were chosen for practical reasons. Table II shows that no substantial increase in the sensitivity of the assays was obtained by measuring the effect of PSC833 on R123 retention, when cells were loaded without PSC833. However, when cells were loaded with PSC833 and subsequently effiuxed, the effect of the modulator was even much smaller than in the accumulation assay in KB8-5 cells, and in KB8 cells it was hardly detec- In order to find an explanation for this apparent discrepancy between the effect of the clinically important modulator PSC833 on R123 accumulation and retention, KB8-5 cells were loaded with 2 lM DNR in a flow-through system until steady-state accumulation was reached. Then a pulse of 25 IM verapamil or 2 pM PSC833 was injected into the DNR-containing medium and the dynamic effect of cellular DNR influx by inhibition of P-gp (and DNR efflux after passage of the modulator) was recorded by measuring the fluorescence of DNR in the medium at the outlet of the flow-through system. DNR influx and efflux by cells were measured by the decrease and increase of the DNR fluorescence in the medium respectively (Figure 2 ). This experiment showed that the efflux of DNR is much more rapidly restored when verapamil instead of PSC833 is used as modulator. Apparently, PSC833 remains much longer in the cells than verapamil, which explains the slight modulator effects on the DNR efflux (see middle column of Table II MRP-but not P-gp-mediated DNR efflux (Versantvoort et al.. 1993) . (Milder et al., 1994) .
overexpressing HL60/ADR cell line, as shown before (Table  III) , we tested the combination of R123 and PSC833 in these cells. However, PSC833 had only a slight effect on R123 accumulation in this cell line. We also tested VCR as a modulator of R123 accumulation in the transfectant SI (MRP) Fgre 3 Uptake and retention of R123 in the GLC4 and GLC4-ADR150 cells. GLC4 (-----) and GLC4-ADRI% (--A--) cells
were loaded for 60 min with 200 ng ml-R123. Retention of R123 was measured after suspending the GLC4 ( -) and GLC4-ADRi,5 (-A-) cells in R123-free medium. (Homolya et al., 1993) . R123 is also a sensitive probe for P-gp, but the accumulation of R123 will be dependent on pH and mitochondrial storage capacity. R123 is not well retained by cells and some leakage of the probe occurs upon the transfer of accumulated cells into dye-free medium at O°C (Holl6 et al.. 1994) .
In this study we compared these different fluorescent dyes by measuring the effect of modulators on their accumulation in P-gp as well as MRP MDR cells. PSC833. a cyclosporin analogue, was chosen as a modulator for P-gp because it has acceptable toxicity when given to patients in concentrations known to reverse P-gp-mediated drug resistance in vitro.
Interestingly, this study provides evidence that the action of PSC833 on P-gp-mediated DNR pumping is much longer lasting than the action of verapamil (Figure 2 ) and the highly MRP-overexpressing COR-L23 R cell line showed increased efflux of R123 (Twentyman et al.. 1994) . no accumulation defect was found in the resistant cell lines GLC4-ADR,1, and HL60 ADR after 60 min incubation with R123. It might be surprising that we found that R123 accumulation after 60 mn is higher in some MRP-overexpressing cell lines than in the parental sensitive cell lines. This may be due to R123 being trapped in cytosolic vesicles containing MRP, as suggested by Cole et al. (1992) . In addition. in contrast to P-gp. an accumulation defect for R123 can only be found after a longer incubation time (Twentyman et al.. 1994 (Jedlitschky et al.. 1994) . Resistance would then depend on the conjugating enzymes as well as on MRP expression. However, it is important to note here that all the MRP-overexpressing cells tested had an accumulation defect for calcein. It has been reported that P-gp extrudes calcein-AM directly from the plasma cell membrane without entering the cellular cytoplasm and that calcein is not a probe for P-gp (Homolya et al.. 1993; Hol1o et al., 1994) . If MRP extrudes calcein-AM by a similar mechanism to P-gp. then our data would suggest that MRP may extrude hydrophobic drugs in a non-conjugated form from the plasma membrane compartment. Elucidation of the mechanism of extrusion by MRP of different classes of drugs needs more research (Versantvoort et al.. 1995b ).
In the GLC4 series the degree of MRP expression was in accordance with drug resistance (Versantvoort et al.. 1995a) as well as with the DNR accumulation defect. However, the SW-1 573 sensitive cell line had a relatively high level of MRP. as detected with the MRPrl antibody. but genistein had no effect on DNR accumulation. One possible explanation for this apparent discrepancy is that cells had to be permeabilised before being stained with MRPrl, since MRPrl is a monoclonal antibody which recognises an internal epitope . Therefore, no distinction could be made between functional MRP in the plasma cell membrane and MRP in structures such as the Golgi system . Since MRP staining of the plasma membrane SW-1573 cells was undetectable by immunocytochemistry . it could well be that this cell line contains more non-functional MRP than other sensitive cell lines. In future, monoclonal antibodies directed against outer epitopes of MRP will clarify this point. Alternatively, a role of intracellular MRP might be inferred from data on the MRP-overexpressing cell line H69 AR, which showed an altered intracellular distribution of doxorubicin but no doxorubicin accumulation defect (Cole et al.. 1992) . For this reason we also explore another approach to detect P-gp-as well as MRP-mediated MDR. by using laser scan microscopy to detect the effect of modulators on the amount of nuclear anthracycline fluorescence in relation to P-gp and MRP expression (Broxterman et al.. 1994; Schuurhuis et al.. 1991) .
Preliminary data from these studies show that in AML P-gpas well as MRP-mediated MDR is at the level of KB8 resistance (Schuurhuis et al.. 1995) .
In conclusion, the present study shows that R123 accumulation in combination with PSC833 is a specific and sensitive test for detecting low levels of P-gp-mediated resistance, which could be of importance in clinical practice. For detection of MRP-mediated resistance. R123 did not appear to be a sensitive probe in a 60 min accumulation assay, whereas the combination of DNR with genistein was more sensitive and selective. The use of calcein-AM with an appropriate modulator (VCR) may be an alternative. The finding that the P-gp-inhibitory action of PSC833 lasts longer than that of verapamil may pertain to the use of PSC833 for modulating MDR in clinical studies.
